D-5699 Dabrafenib, Methanesulfonate Salt, >99%

Synonyms : [Dabrafenib Mesylate] [GSK2118436] [GSK2118436B]

Related Terms : [Tafinlar]

Prices_reduced
  • Size
  • US $
  • £
  • ¥
  • 10 mg
  • 44
  • 41
  • 35
  • 5,700
  • Add to Cart Qty:
  • In stock
  • 25 mg
  • 69
  • 65
  • 55
  • 8,900
  • Add to Cart Qty:
  • In stock
  • 50 mg
  • 77
  • 73
  • 62
  • 10,000
  • Add to Cart Qty:
  • In stock
  • 100 mg
  • 128
  • 121
  • 103
  • 16,500
  • Add to Cart Qty:
  • In stock
  • 200 mg
  • 199
  • 189
  • 160
  • 25,700
  • Add to Cart Qty:
  • In stock
  • 500 mg
  • 292
  • 277
  • 235
  • 37,800
  • Add to Cart Qty:
  • In stock
  • 1 g
  • 443
  • 421
  • 357
  • 57,300
  • Add to Cart Qty:
  • In stock
  • 2 g
  • 770
  • 732
  • 620
  • 99,500
  • Add to Cart Qty:
  • In stock
  • 5 g
  • 1,740
  • 1,654
  • 1,402
  • 225,000
  • Add to Cart Qty:
  • In stock
  • 10 g
  • 2,660
  • 2,529
  • 2,143
  • 343,900
  • Add to Cart Qty:
  • In stock

Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.

To receive a Formal Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities Free Shipping and Handling to the U.S. and 33 Other Countries
  • M.W. 615.67
  • C23H20F3N5O2S2CH4O3S
  • [1195768-06-9]

Select Lot Number to view Certificate of Analysis

View the SDS for this product

  • This research compound is the methanesulfonate salt form of dabrafenib.  Please see the free base form of dabrafenib, Cat. No. D-5678, Dabrafenib, Free Base, for further technical information.
  • This dabrafenib product is the methanesulfonate salt, whose CAS number is given above. The CAS number of the free base form is 1195765-45-7.
  • Dabrafenib Methanesulfonate Salt is the active ingredient in the drug product sold under the trade name Tafinlar®.  This drug has been approved in at least one country for use in patients with mutated metastatic melanoma. NOTE: THE DABRAFENIB SOLD BY LC LABORATORIES FOR RESEARCH IS NOT TAFINLAR®, AND IS NOT FOR HUMAN USE.
  • Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use
  • This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
  • Not available in some countries; not available to some institutions; not available for some uses.
549